Results 271 to 280 of about 143,942 (291)
Some of the next articles are maybe not open access.
PNPLA3 and obesity: a synergistic relationship in NAFLD
Nature Reviews Gastroenterology & Hepatology, 2017NAFLD, the hepatic manifestation of the metabolic syndrome, is a multifactorial condition — environmental factors influence an inherited genetic risk. Stender et al. now describe the additive effect of obesity and NAFLD-associated genetic polymorphisms on steatosis, elevated serum alanine aminotransferase levels and cirrhosis, remarkably illustrating ...
Mann JP, Anstee QM
openaire +3 more sources
NAFLD and NAFLD-related HCC in Asia: Burden and Surveillance
Journal of Clinical and Experimental HepatologyNon-alcoholic fatty liver disease (NAFLD) is rapidly emerging as a leading etiology of chronic liver disease (CLD) in Asia. The increasing incidence of NAFLD is projected to drive a surge in NAFLD-related hepatocellular carcinoma (HCC). A notable characteristic of NAFLD-HCC is its capacity for development in individuals without cirrhosis in more than a
Jia H. Koh +5 more
openaire +2 more sources
Nicht-alkoholische Fettlebererkrankung (NAFLD)
DMW - Deutsche Medizinische Wochenschrift, 2015Leicht, Hans Benno +2 more
openaire +1 more source
Journal of Pediatric Gastroenterology and Nutrition, 2018
Praveen Kumar Conjeevaram Selvakumar +2 more
openaire +1 more source
Praveen Kumar Conjeevaram Selvakumar +2 more
openaire +1 more source
Nanoparticles in NAFLD therapeutics
Nature Reviews Gastroenterology & Hepatology, 2023openaire +2 more sources

